Tibco Introduces Spotfire Clinical to Improve Clinical Trials and Accelerate Drug Development

June 21, 2010

Company News Release

TIBCO Software Inc. announced the launch of  TIBCO Spotfire® Clinical, providing an in-memory, analytics platform on the market that aims to allow clinical development teams to make faster and more accurate decisions. Through visual and interactive exploration of clinical data, Spotfire Clinical® will enable actionable decisions that enhance patient safety, streamline operations and accelerate time to market for new medications and devices.  
 
Clinical development teams can visualize and interact with operational, clinical and safety data in a single interface to support forward-looking decisions. By leveraging the new integrated S+/R statistics and predictive analytics capabilities of the TIBCO Spotfire® Analytics Platform, users will be able to conduct advanced what-if scenarios and analysis to gain insights into data, without the intervention of IT resources or biostatisticians.
 
“We use TIBCO Spotfire software for analyzing and reviewing operational and medical data on all our clinical trials,” said John Keilty vice president of IT and Informatics, Infinity Pharmaceuticals. “With Spotfire, all our clinical, safety and operational data are available in real time. This enables us to shorten the time between critical development gates, and to meet key milestones sooner while simultaneously managing safety risk.”

Related Content:

News